Track the 金域医学 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 金域医学 has logged 3 insider filings. Market capitalisation: €12.9bn. The latest transaction was reported on 15 July 2024 (Purchase). Among the most active insiders: 郝必喜. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
金域医学是一家在中国专门从事医学诊断服务和实验室检测的公司。该公司为医疗保健专业人士提供创新和高质量的健康解决方案。